US Stock MarketDetailed Quotes

ALAB Astera Labs

Watchlist
  • 74.350
  • -1.400-1.85%
Close Feb 28 16:00 ET
  • 74.680
  • +0.330+0.44%
Post 19:59 ET
12.06BMarket Cap-116.17P/E (TTM)

Astera Labs Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Astera Labs Q4 2024 Earnings Date

Currency：USDFeb 10, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
127.91M
141.10M
+13.19M
Beat Est.
--
+179.32%
+10.31%
EPS
0.03
0.14
+0.11
Beat Est.
--
+49.04%
+350.16%
Analyst Rating
Strong Buy

Feb 28, 2025

Astera Labs Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 159.365M--
--2025/Q1-- / 151.396M--
Feb 10, 20252024/Q4141.096M / 127.905M--
Nov 4, 20242024/Q3113.086M / 97.438M--
Aug 6, 20242024/Q276.850M / 72.527M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 159.365M--
--2025/Q1-- / 151.396M--
Feb 10, 20252024/Q4141.096M / 127.905M--
Nov 4, 20242024/Q3113.086M / 97.438M--
Aug 6, 20242024/Q276.850M / 72.527M--

Unlock Free Earnings Estimates

Astera Labs Earnings Reports

  • Astera Labs | 10-K: Annual report

    Feb 14 13:18 ET

  • Astera Labs | 8-K: Astera Labs Announces Financial Results for the Fourth Quarter of Fiscal Year 2024

    Feb 10 16:17 ET

  • Astera Labs | 10-Q: Quarterly report

    Nov 5, 2024 13:23 ET

  • Astera Labs | 8-K: Astera Labs Announces Financial Results for the Third Quarter of Fiscal Year 2024

    Nov 4, 2024 16:13 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Strong Buy

    • Buy

      92.86%

    • Hold

      7.14%

    • Sell

      0.00%

    Price Target

    No Data